USANA Health Sciences Reports Fourth Quarter and Full Year 2024 Results and Provides Fiscal Year 2025 Outlook

Rhea-AI Summary

USANA Health Sciences (NYSE: USNA) reported Q4 2024 financial results and completed acquisition of 78.8% stake in Hiya Health Products. Q4 net sales decreased to $214M from $221M year-over-year, with net earnings falling to $4.5M from $16.8M. Diluted EPS declined to $0.23 from $0.87.

For full-year 2024, net sales were $855M compared to $921M in 2023, with net earnings of $42.0M versus $63.8M. Active customers decreased to 454,000 from 483,000.

The company provided FY2025 guidance projecting:

• Net sales between $920M-$1.0B (8-17% growth)
• Net earnings of $29M-$41M
• Diluted EPS of $1.50-$2.20

The outlook includes Hiya's expected contribution of $145M-$160M in sales. The company maintains a strong balance sheet with $182M in cash and cash equivalents, despite $206M investment in Hiya acquisition.

Positive

• 7% sequential net sales growth in Q4
• Strong cash position with $182M in cash and equivalents
• Americas & Europe region showed year-over-year growth
• Strategic acquisition of Hiya Health completed
• $62M remaining in share repurchase authorization

Negative

• Q4 net earnings dropped 73% YoY to $4.5M
• Q4 diluted EPS declined 74% YoY to $0.23
• Active customers decreased 6% YoY to 454,000
• FY2024 net sales declined 7.2% to $855M
• FY2024 net earnings fell 34% to $42.0M

Insights

Financial Analyst

USANA's Q4 and full-year 2024 results reveal a company in transition, strategically pivoting while navigating persistent headwinds. The 73% year-over-year decline in Q4 net earnings ($4.5M vs $16.8M) and 34% drop in annual earnings ($42M vs $63.8M) underscore significant operational challenges, particularly in the Asia Pacific region where cautious consumer sentiment continues to hamper customer acquisition and retention. The 6% decline in active customers (454,000 vs 483,000) serves as a concerning leading indicator for the core business.

The acquisition of Hiya Health Products represents a strategic diversification beyond USANA's traditional direct selling model into the high-growth children's wellness category with a subscription-based approach. This $206 million investment signals management's recognition that their core business needs complementary growth vectors. The transaction's structure is particularly noteworthy - by acquiring a 78.8% controlling stake while retaining Hiya's founders, USANA gains strategic control while preserving entrepreneurial leadership.

The 2025 guidance reveals two distinct stories: modest expectations for the legacy business ($775-840 million, including a $30 million currency headwind) versus ambitious growth projections for Hiya (29-42% growth to $145-160 million). The substantial gap between projected GAAP EPS ($1.50-$2.20) and Adjusted EPS ($2.35-$3.00) highlights the acquisition's significant near-term impact on reported earnings through amortization and integration costs.

Management's introduction of non-GAAP metrics following the acquisition warrants investor scrutiny. While providing enhanced comparability, these adjustments also effectively mask approximately $0.85 per share in acquisition-related costs. The projected tax rate of 41.5-45.0% is unusually high and will substantially impact reported earnings.

USANA's direct sales revitalization strategy centers on four initiatives: accelerated product innovation, incentive structure enhancements, brand messaging improvements, and increased field engagement. These approaches, while sensible, represent standard industry practices rather than truly disruptive innovations. The effectiveness of these initiatives against persistent headwinds in Asia remains uncertain.

The company's financial position remains solid with $182 million in cash post-acquisition, though the suspension of share repurchases despite $62 million in remaining authorization suggests capital preservation is a priority. Investors should note that 2025 being a 53-week fiscal year will artificially inflate year-over-year growth comparisons by approximately 2%.

The divergence between regions - growth in Americas & Europe versus continued challenges in Asia Pacific - highlights the uneven recovery in USANA's markets. The potential impact of proposed tariffs, while not quantified in guidance, represents an additional risk factor for this global supply chain.

SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) (the “Company”) today announced financial results for its fiscal fourth quarter and fiscal year ended December 28, 2024. The Company completed the acquisition of a 78.8% controlling ownership stake of Hiya Health Products, LLC (“Hiya”) on December 23, 2024. Consequently, the Company’s fourth quarter and fiscal year 2024 include the effect of less than a week of Hiya’s operating results, which were not significant to the Company’s consolidated results for the same periods. In light of the Hiya acquisition, the Company is now including metrics for Adjusted diluted EPS⁽¹⁾ and Adjusted EBITDA⁽²⁾. Net earnings, Diluted EPS, Adjusted diluted EPS⁽¹⁾ and Adjusted EBITDA⁽²⁾ in this press release represent amounts attributable to USANA.

Key Financial Results and Guidance

Fourth Quarter 2024 vs. Fourth Quarter 2023

• Net sales of $214 million versus $221 million.
• Net earnings of $4.5 million as compared to $16.8 million.
• Diluted EPS of $0.23 as compared with $0.87.
• Adjusted diluted EPS⁽¹⁾ of $0.64 as compared with $0.87.
• Adjusted EBITDA⁽²⁾ of $25 million versus $32 million.
• USANA Active Customers of 454,000 versus 483,000.

Fiscal Year 2024 vs. Fiscal Year 2023

• Net sales of $855 million as compared with $921 million.
• Net earnings of $42.0 million as compared to $63.8 million.
• Diluted EPS of $2.19 versus $3.30.
• Adjusted diluted EPS⁽¹⁾ of $2.59 as compared with $3.30.
• Adjusted EBITDA⁽²⁾ of $110 million versus $128 million.

Fiscal Year 2025 Outlook

• Consolidated net sales between $920 million and $1.0 billion, or 8% - 17% growth.
• Net earnings between $29 million and $41 million.
• Diluted EPS between $1.50 and $2.20.
• Adjusted Diluted EPS⁽¹⁾ between $2.35 and $3.00.
• Adjusted EBITDA⁽²⁾ between $107 million and $123 million.

Q4 2024 Financial Performance

Consolidated Results
(Net earnings, EPS and EBITDA figures represent amounts attributable to USANA)		Year-over-Year	Sequentially
Net Sales	$214 million	-3% (No meaningful FX impact)	+7%
Net Earnings	$4.5 million	-73%	-58%
Diluted EPS	$0.23	-74%	-59%
Adjusted Diluted EPS(1)	$0.64	-26%	+14%
Adjusted EBITDA(2)	$25 million	-21%	+4%

“USANA delivered fourth quarter results above our internal expectations, highlighted by 7% sequential net sales growth,” said Jim Brown, President and Chief Executive Officer. “Positive momentum in the Americas & Europe region generated year-over-year and sequential sales growth in this region while performance in our Asia Pacific region declined slightly and was in line with our expectations. On a consolidated basis, we generated solid cash flow during the quarter and our balance sheet remains in a healthy net cash position. Overall, we delivered solid performance to finish the year and are confident in our ability to build on this performance in 2025.”

Mr. Brown added, “We also completed our acquisition of Hiya during the quarter, which is a meaningful milestone for USANA and an exciting addition to our business. Hiya is a growing, highly cash generative, direct-to-consumer children’s wellness brand. Hiya has an experienced management team that continues to lead the company and a compelling subscription business model that we believe is positioned to deliver long-term sustainable growth over the next several years. We look forward to supporting Hiya as they build upon their leadership position in the children’s health and wellness market.”

Fiscal Year 2024 vs. Fiscal Year 2023 Financial Performance

Consolidated Results
Net Sales	$855 million	-7% YOY
		-6% constant currency
		-$14 million YOY FX impact
Net Earnings	$42.0 million	-34%
Diluted EPS	$2.19	-34%
Adjusted Diluted EPS(1)	$2.59	-21%
Adjusted EBITDA(2)	$110 million	-14%
Net earnings, EPS and EBITDA figures represent amounts attributable to USANA

Mr. Brown continued, “Full year operating results reflected continued, cautious consumer sentiment in many of our key Asia Pacific markets. This made it difficult to attract new customers and generate positive momentum throughout the year. Notwithstanding these factors, our commercial team made progress on several meaningful initiatives which will begin rolling out across our direct sales business this year. We are confident that these initiatives will lay the foundation for the Company to generate long term growth.”

Q4 2024 Regional Results:

Asia Pacific Region
			Year- Over-Year	Year-over-Year (Constant Currency)	Sequentially
Net Sales		$167 million	-6%	No material FX impact	+4%
USANA Active Customers		361,000	-6%	n.a.	Flat

Asia Pacific Sub-Regions
			Year- Over-Year	Year-over-Year (Constant Currency)	Sequentially
Greater China	Net Sales	$113 million	-3%	No material FX impact	+10%
	USANA Active	246,000	-4%	n.a.	+1%
	Customers
North Asia	Net Sales	$17 million	-25%	-21%	-19%
	USANA Active	38,000	-21%	n.a.	-7%
	Customers
Southeast Asia Pacific	Net Sales	$38 million	-3%	-4%	+2%
	USANA Active	77,000	-4%	n.a.	+1%
	Customers

Americas and Europe Region
			Year- Over-Year	Year-over-Year (Constant Currency)	Sequentially
Net Sales		$44 million	+1%	+3%	+11%
USANA Active Customers		93,000	-7%	n.a.	+1%

Hiya contributed approximately $2 million to net sales during the fourth quarter and fiscal year ended 2024.

Balance Sheet and Share Repurchase Activity

During the fourth quarter, the Company continued to generate strong operating cash flow and invested approximately $206 million for the acquisition of Hiya. Consequently, the Company ended the year with $182 million in cash and cash equivalents. The Company did not repurchase any shares during the quarter. As of December 28, 2024, the Company had approximately $62 million remaining under the current share repurchase authorization.

Fiscal Year 2025 Outlook

Mr. Brown continued, “Our growth strategy for the direct sales business in 2025 is centered on our Associate sales force and providing them with the resources needed to generate sustainable active customer growth. This growth strategy includes several key initiatives, including (i) a higher cadence of new product launches and improvements to existing products tailored to local markets, (ii) strategic enhancements and modifications to our Associate incentive offering, which are intended to incent customer growth and improve pay for performance, (iii) strengthening our brand messaging, story, and value proposition, and (iv) accelerating Associate engagement activities in our regions around the world. I’m confident that the successful execution of these initiatives will position us for growth going forward.

“Hiya’s strategic priorities for this year include capitalizing on recent product launches to drive further growth in its direct-to-consumer model, expanding strategic partnerships, and laying the groundwork for channel expansion. We are also working closely with the Hiya team to identify both short- and long-term synergy opportunities. Overall, we remain confident that the Hiya team, which continues to be led by co-founders Darren Litt and Adam Gillman, will deliver strong growth in 2025.”

The Company is providing its outlook for fiscal year 2025, as detailed in the table below:

	Twelve Months Ended January 3, 2026
	Range
Consolidated net sales	$920 million to $1.0 billion
Net Earnings	$29 million to $41 million
Diluted EPS	$1.50 to $2.20
Adjusted diluted EPS(1)	$2.35 to $3.00
Adjusted EBITDA(2)	$107 million to $123 million

Doug Hekking, Chief Financial Officer, said, “We are introducing our consolidated fiscal 2025 outlook, which now includes additional non-GAAP financial metrics to help provide transparency and comparability with prior years following our acquisition of Hiya. Notably, we have included certain transaction-related expenses and integration costs for the Hiya acquisition in our outlook. Furthermore, the purchase price allocation for this acquisition includes a significant amount recognized as intangible assets with material amortization expense that will have a non-cash impact on reported results. Therefore, we are providing estimates for Adjusted diluted EPS⁽¹⁾ and Adjusted EBITDA⁽²⁾ as part of our outlook to provide enhanced comparability between periods and improved clarity on cash flow generation of the combined enterprise on a year-over-year basis. Additionally, our outlook does not currently reflect the potential increased costs of proposed tariffs on our business as we continue to assess the changing business environment.”

The Company’s outlook reflects:

• Net sales from the USANA business of $775 to $840 million, which includes an expected unfavorable currency exchange rate impact of approximately $30 million, or -4% on net sales;
• Net sales from Hiya of $145 to $160 million, reflecting a year-over-year range of +29% to +42%;
• Effective tax rate of 41.5% to 45.0%;
• Annualized diluted share count of 19.1 million; and
• Fiscal 2025 is a 53-week year and includes one additional week of sales compared to fiscal 2024. Prior to 2025, the last 53-week year was in fiscal 2020.

_________________________

(1) Adjusted Diluted Earnings Per Share is a non-GAAP financial measure. The Company excludes acquisition-related costs, such as business transaction costs, integration expense and amortization expense from acquisition related intangible assets in calculating Adjusted Diluted Earnings Per Share. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Diluted Earnings Per Share (GAAP) to Adjusted Diluted Earnings Per Share (Non-GAAP)” in this press release for an explanation and reconciliation of this non-GAAP financial measure.

(2) Adjusted EBITDA is a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Net Earnings (GAAP) to Adjusted EBITDA (Non-GAAP)” in this press release for an explanation and reconciliation of this non-GAAP financial measure.

Non-GAAP Financial Measures

This press release contains the non-GAAP financial measures Adjusted EBITDA and Adjusted diluted EPS. Adjusted EBITDA is a Non-GAAP financial measure of earnings before interest, taxes, depreciation, and amortization that also excludes certain adjustments as indicated below in the reconciliation from net earnings. Adjusted diluted EPS is a Non-GAAP financial measure of diluted earnings per share that excludes certain adjustments as indicated below in the reconciliation from diluted EPS.

Adjusted EBITDA (non-GAAP) is net earnings (loss) (its most directly comparable GAAP financial measure) adjusted for interest expense, net, (benefit from) provision for income taxes, depreciation and amortization, non-cash share-based compensation, and transaction-related expenses and integration costs for the Hiya acquisition. Adjusted EBITDA attributable to USANA (non-GAAP) is Adjusted EBITDA (non-GAAP) further adjusted to exclude the Adjusted EBITDA attributable to non-controlling interest related to Hiya.

Adjusted diluted earnings per share (non-GAAP) is diluted earnings (loss) per share (its most directly comparable GAAP financial measure) adjusted for amortization of intangible assets, transaction-related expenses, and integration costs related to the Hiya acquisition.

Management believes that Adjusted EBITDA (non-GAAP), Adjusted EBITDA attributable to USANA (non-GAAP), and Adjusted diluted earnings per share (non-GAAP), along with GAAP measures used by management, most appropriately reflect how the Company measures the business internally.

The Company prepares its financial statements using U.S. generally accepted accounting principles (“GAAP”) and investors should not directly compare with or infer relationship from any of the Company’s operating results presented in accordance with GAAP to Adjusted EBITDA and Adjusted diluted earnings per share. Non-GAAP financial measures have limitations in their usefulness to investors because they have no standardized meaning prescribed by GAAP and are not prepared under any comprehensive set of accounting rules or principles. In addition, other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of non-GAAP financial information as a tool for comparison. As a result, the non-GAAP financial information of Hiya is presented for supplemental informational purposes only and should not be considered in isolation from, or as a substitute for financial information presented in accordance with GAAP.

Reconciliation of Diluted Earnings Per Share (GAAP) to Adjusted Diluted Earnings Per Share (non-GAAP)
	Three Months Ended			Three Months Ended							Twelve Months Ended
	September 28, 2024			December 28, 2024				December 30, 2023			December 28, 2024				December 30, 2023
Net earnings attributable to USANA (GAAP)	$	10,607		$	4,454			$	16,766		$	42,030			$	63,788
Earnings per common share - Diluted (GAAP)	$	0.56		$	0.23			$	0.87		$	2.19			$	3.30
Weighted Average common shares outstanding - Diluted		19,083			19,104				19,253			19,162				19,345
Adjustment to net earnings:
Transaction costs - Hiya	$	-		$	8,243			$	-		$	8,243			$	-
Integration and transition costs - Hiya		-			-				-			-				-
Inventory step-up - Hiya		-			38				-			38				-
Amortization of intangible assets - Hiya		-			294				-			294				-
Adjustments to net earnings attributable to non-controlling interest		-			(70	)			-			(70	)			-
Income tax effect of adjustments to net earnings		-			(823	)			-			(823	)			-
Adjusted net earnings attributable to USANA	$	10,607		$	12,136			$	16,766		$	49,712			$	63,788
Adjusted earnings per common share - Diluted	$	0.56		$	0.64			$	0.87		$	2.59			$	3.30
Weighted average common shares outstanding - Diluted		19,083			19,104				19,253			19,162				19,345

Reconciliation of Net Earnings (GAAP) to Adjusted EBITDA (non-GAAP)
	Three Months Ended				Three Months Ended								Twelve Months Ended
	September 28, 2024				December 28, 2024				December 30, 2023				December 28, 2024				December 30, 2023
Net earnings attributable to USANA (GAAP)	$	10,607			$	4,454			$	16,766			$	42,030			$	63,788
Net earnings attributable to non-controlling interest		-				30				-				30				-
Net earnings	$	10,607			$	4,484			$	16,766			$	42,060			$	63,788
Adjustments:
Income taxes		8,001				5,945				9,845				34,291				38,665
Interest (income) expense		(3,093	)			(2,609	)			(2,760	)			(11,038	)			(9,375	)
Depreciation and amortization		5,559				5,590				4,871				21,935				20,395
Amortization of intangible assets - Hiya		-				294				-				294				-
Earnings before interest, taxes, depreciation, and amortization (EBITDA)		21,074				13,704				28,722				87,542				113,473
Add EBITDA adjustments:
Non-cash share-based compensation		3,542				3,613				3,643				14,558				14,595
Transaction costs - Hiya		-				8,243				-				8,243				-
Integration and transition costs - Hiya		-				-				-				-				-
Inventory step-up - Hiya		-				38				-				38				-
Consolidated adjusted EBITDA		24,616				25,598				32,365				110,381				128,068
Less: Adjusted EBITDA attributable to non-controlling interest		-				(101	)			-				(101	)			-
Adjusted EBITDA attributable to USANA	$	24,616			$	25,497			$	32,365			$	110,280			$	128,068

Management Commentary Document and Conference Call

For further information on the USANA’s operating results, please see the Management Commentary document, which has been posted on the Company’s website (http://ir.usana.com) under the Investor Relations section. USANA’s management team will hold a conference call and webcast to discuss today’s announcement with investors on Wednesday, February 26, 2025 at 11:00 AM Eastern Time. Investors may listen to the call by accessing USANA’s website at http://ir.usana.com. The call will consist of brief opening remarks by the Company’s management team, followed by a questions and answers session.

Safe Harbor

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These forward-looking statements are based on current plans, expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Words such as “expect,” “enhance,” “drive,” “anticipate,” “intend,” “improve,” “promote,” “should,” “believe,” “continue,” “plan,” “goal,” “opportunity,” “estimate,” “predict,” “may,” “will,” “could,” and “would,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Such forward-looking statements include, but are not limited to, statements that Hiya is a growing, highly cash-generative brand that is positioned to deliver long-term sustainable growth over the next several years and strong growth in 2025; statements about the Company’s long-term growth; and the statements under the sub-heading “Fiscal Year 2025 Outlook.” Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control, including: risks relating to global economic conditions generally, including continued inflationary pressure around the world and negative impact on our operating costs, consumer demand and consumer behavior in general; reliance upon our network of independent Associates; risk that our Associate compensation plan, or changes that we make to the compensation plan, will not produce desired results, benefit our business or, in some cases, could harm our business; risk associated with our launch of new products or reformulated existing products; risks related to governmental regulation of our products, manufacturing and direct selling business model in the United States, China and other key markets; potential negative effects of deteriorating foreign and/or trade relations between or among the United States, China and other key markets, including potential adverse impact from tariffs levied by the US, China, or other markets that are important to the Company; potential negative effects from geopolitical relations and conflicts around the world, including the Russia-Ukraine conflict and the conflict in Israel; compliance with data privacy and security laws and regulations in our markets around the world; potential negative effects of material breaches of our information technology systems to the extent we experience a material breach; material failures of our information technology systems; adverse publicity risks globally; risks associated with early stage operations in India and future international expansion and operations; uncertainty relating to the fluctuation in U.S. and other international currencies; the potential for a resurgence of COVID-19, or another pandemic, in any of our markets in the future and any related impact on consumer health, domestic and world economies, including any negative impact on discretionary spending, consumer demand, and consumer behavior in general; risk that the Hiya acquisition disrupts each company’s current plans and operations; the diversion of the attention of the management teams of USANA and Hiya from ongoing business operations; the ability of to retain key personnel of Hiya; the ability to realize the benefits of the acquisition, including efficiencies and cost synergies; the ability to successfully integrate Hiya’s business with USANA’s business, at all or in a timely manner; and the amount of the costs, fees, expenses and charges related to the acquisition. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this press release set forth our beliefs as of the date hereof. We do not undertake any obligation to update any forward-looking statement after the date hereof or to conform such statements to actual results or changes in the Company’s expectations, except as required by law.

About USANA

USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany, Spain, Romania, Italy, and India. More information on USANA can be found at www.usana.com. USANA also holds a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company with a variety of clean-label products. More information on Hiya can be found at www.hiyahealth.com.

USANA Health Sciences, Inc.
Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
		Quarter Ended							Twelve Months Ended
		28-Dec-24				30-Dec-23			28-Dec-24				30-Dec-23
Net sales		$	213,613			$	221,083		$	854,503			$	921,010
Cost of sales			38,553				42,319			161,212				176,693
Gross profit			175,060				178,764			693,291				744,317
Operating expenses:
Associate incentives			93,502				95,881			363,699				394,257
Selling, general and administrative			73,348				58,664			263,268				256,989
Earnings from operations			8,210				24,219			66,324				93,071
Other income (expense), net			2,219				2,392			10,027				9,382
Earnings before income taxes			10,429				26,611			76,351				102,453
Income taxes			5,945				9,845			34,291				38,665
Net earnings		$	4,484			$	16,766		$	42,060			$	63,788
Less (net earnings) loss attributable to non-controlling interest			(30	)			-			(30	)			-
Net earnings attributable to USANA		$	4,454			$	16,766		$	42,030			$	63,788
Earnings per share - diluted		$	0.23			$	0.87		$	2.19			$	3.30
Weighted average shares outstanding - diluted			19,104				19,253			19,162				19,345

USANA Health Sciences, Inc.
Consolidated Balance Sheets
(In thousands)
(Unaudited)
		As of			As of
		28-Dec-24			30-Dec-23
ASSETS
Current Assets
Cash and cash equivalents		$	181,768		$	330,420
Inventories			69,735			61,454
Prepaid expenses and other current assets			27,684			25,872
Total current assets			279,187			417,746
Property and equipment, net			94,565			99,814
Goodwill			144,168			17,102
Intangible assets, net			151,823			29,919
Deferred tax assets			19,644			13,284
Other assets*			58,806			54,892
Total assets		$	748,193		$	632,757
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable		$	11,984		$	10,070
Line of credit - short term			23,000			786
Other current liabilities			104,641			107,989
Total current liabilities			139,625			118,845
Deferred tax liabilities			4,073			4,552
Other long-term liabilities			18,163			12,158
Non-controlling interest			54,223			-
Stockholders' equity			532,109			497,202
Total liabilities and stockholders' equity		$	748,193		$	632,757

*Includes noncurrent inventories of $2,688 and $3,128 as of 28-Dec-24 and 30-Dec-23, respectively. Total inventories were $72,423 and $64,582 as of 28-Dec-24 and 30-Dec-23, respectively.

USANA Health Sciences, Inc.
Sales by Region
(In thousands)
(Unaudited)
		Quarter Ended
		December 28, 2024						December 30, 2023						Change from prior year							Currency impact on sales				% change excluding currency impact
Asia Pacific
Greater China		$	112,587		52.7	%		$	115,921		52.4	%		$	(3,334	)		(2.9	%)		$	353			(3.2	%)
Southeast Asia Pacific			38,061		17.8	%			39,116		17.7	%			(1,055	)		(2.7	%)			562			(4.1	%)
North Asia			16,542		7.8	%			22,065		10.0	%			(5,523	)		(25.0	%)			(883	)		(21.0	%)
Asia Pacific Total			167,190		78.3	%			177,102		80.1	%			(9,912	)		(5.6	%)			32			(5.6	%)
Americas and Europe			44,453		20.8	%			43,981		19.9	%			472			1.1	%			(1,061	)		3.5	%
Total USANA			211,643		99.1	%			221,083		100.0	%			(9,440	)		(4.3	%)			(1,029	)		(3.8	%)
Hiya			1,970		0.9	%									1,970							-
Consolidated Total		$	213,613		100.0	%		$	221,083		100.0	%		$	(7,470	)		(3.4	%)		$	(1,029	)		(2.9	%)

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES ACTIVE ASSOCIATES AND ACTIVE PREFERRED CUSTOMERS BY REGION (unaudited)
Active Associates by Region(1)
(Unaudited)
		As of
		December 28, 2024					December 30, 2023
Asia Pacific
Greater China		67,000		35.4	%		70,000		35.0	%
Southeast Asia Pacific		51,000		27.0	%		52,000		26.0	%
North Asia		26,000		13.8	%		32,000		16.0	%
Asia Pacific Total		144,000		76.2	%		154,000		77.0	%
Americas and Europe		45,000		23.8	%		46,000		23.0	%
		189,000		100.0	%		200,000		100.0	%
Active Preferred Customers by Region (2)
(Unaudited)
		As of
		December 28, 2024					December 30, 2023
Asia Pacific
Greater China		179,000		67.6	%		185,000		65.4	%
Southeast Asia Pacific		26,000		9.8	%		28,000		9.9	%
North Asia		12,000		4.5	%		16,000		5.6	%
Asia Pacific Total		217,000		81.9	%		229,000		80.9	%
Americas and Europe		48,000		18.1	%		54,000		19.1	%
		265,000		100.0	%		283,000		100.0	%

(1) Associates are independent distributors of our products who also purchase our products for their personal use. We only count as active those Associates who have purchased from us any time during the most recent three-month period, either for personal use or resale.

(2) Preferred Customers purchase our products strictly for their personal use and are not permitted to resell or to distribute the products. We only count as active those Preferred Customers who have purchased from us any time during the most recent three-month period. China utilizes a Preferred Customer program that has been implemented specifically for that market.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225808997/en/

Investor contact:

Andrew Masuda

Investor Relations

(801) 954-7201

investor.relations@usanainc.com

Media contact:

Sarah Searle

(801) 954-7626

media@usanainc.com

Source: USANA Health Sciences, Inc.

FAQ

What was USANA's Q4 2024 revenue and how did it compare to Q4 2023?

USANA's Q4 2024 revenue was $214 million, down from $221 million in Q4 2023, representing a 3.2% decrease.

How much did USANA pay for the Hiya Health acquisition in 2024?

USANA invested approximately $206 million to acquire a 78.8% controlling stake in Hiya Health Products in December 2024.

What is USANA's revenue guidance for fiscal year 2025?

USANA projects FY2025 consolidated net sales between $920 million and $1.0 billion, representing 8-17% growth.

How many active customers did USANA have in Q4 2024?

USANA reported 454,000 active customers in Q4 2024, down from 483,000 in Q4 2023.

What is Hiya's expected revenue contribution to USANA in 2025?

Hiya is expected to contribute between $145-160 million in net sales for FY2025, representing 29-42% year-over-year growth.